Kirill V. Rychev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kirill V. Rychev has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexander O. Terent’ev
N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prospekt, Moscow 119991, Russia
1 shared publication - Alexander S. Tikhomirov
Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russian Federation
1 shared publication - Alexey M. Egorov
Lomonosov Moscow State University, Enzymology Division, Moscow, Russian Federation
1 shared publication - Andrey Egorovich Shchekotikhin
Gause Institute of New Antibiotics, Moscow, Russia
1 shared publication Irina P. Andreeva
Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russian Federation
1 shared publication- Konstantin Aleksandrovich Kochetkov
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 119334 Moscow, Russian Federation
1 shared publication
Latest Publications
- 1 September 2026
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 95 (9) , RCR5233
Asymmetric catalysis in microreactor systems of flow chemistry: a powerful tool in the synthesis of biologically active compounds
The review systematizes the achievements in the relevant field of asymmetric catalysis implemented in microreactor synthesis. The main types of stereoselective reactions involving organocatalysts, metal complexes, and enzymes in both homogeneous and heterogeneous designs are systematically compared. The results obtained in batch and continuous-flow processes are presented and general patterns determining the efficiency of various types of catalysts are identified. The data are analyzed in relation to the synthesis of pharmaceutically important chiral compounds and intermediates, including compounds that possess anticoagulant, antidepressant, antiepileptic, antiviral, and other types of biological activity. Taken together, the presented data indicate that asymmetric catalysis in microfluidic systems is both an important tool for fundamental research of stereoselective reactions and a promising technology platform for laboratory and industrial synthesis of enantiomerically pure biologically active compounds. The bibliography includes 298 references.
- 1 September 2026
- Published by Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii in Russian Chemical Reviews
- Vol. 95 (9) , RCR5233
Asymmetric catalysis in microreactor systems of flow chemistry: a powerful tool in the synthesis of biologically active compounds
The review systematizes the achievements in the relevant field of asymmetric catalysis implemented in microreactor synthesis. The main types of stereoselective reactions involving organocatalysts, metal complexes, and enzymes in both homogeneous and heterogeneous designs are systematically compared. The results obtained in batch and continuous-flow processes are presented and general patterns determining the efficiency of various types of catalysts are identified. The data are analyzed in relation to the synthesis of pharmaceutically important chiral compounds and intermediates, including compounds that possess anticoagulant, antidepressant, antiepileptic, antiviral, and other types of biological activity. Taken together, the presented data indicate that asymmetric catalysis in microfluidic systems is both an important tool for fundamental research of stereoselective reactions and a promising technology platform for laboratory and industrial synthesis of enantiomerically pure biologically active compounds. The bibliography includes 298 references.
- 20 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 302 (Pt 3) , 118376
Rational design of 1H-pyrrole-2-carboxylic acid inhibitors of NDM-1 metallo-β-lactamase restoring β-lactam efficacy against resistant Enterobacterales
- 20 November 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 302 (Pt 3) , 118376
Rational design of 1H-pyrrole-2-carboxylic acid inhibitors of NDM-1 metallo-β-lactamase restoring β-lactam efficacy against resistant Enterobacterales